Summary
Quest Diagnostics Inc. (DGX) announced a change to its Board of Directors on August 17, 2021, through an 8-K filing. The Board increased its size from nine to ten directors and elected Tracey C. Doi as a new independent director, effective August 16, 2021. Ms. Doi brings significant financial expertise, currently serving as Chief Financial Officer and Group Vice President of Toyota Motor North America.
Key Highlights
- 1Board of Directors size increased from 9 to 10 members.
- 2Tracey C. Doi appointed as a new independent director.
- 3Ms. Doi's appointment is effective immediately as of August 16, 2021.
- 4Ms. Doi currently holds the position of CFO and Group Vice President at Toyota Motor North America.
- 5The Board determined Ms. Doi meets independence standards under NYSE listing rules and company guidelines.
- 6Ms. Doi has been appointed to the Audit and Finance and Cybersecurity Committees of the Board.
- 7Ms. Doi will receive standard non-employee director compensation, including a one-time restricted share unit grant valued at $135,617.
Frequently Asked Questions
Tracey C. Doi is the newly elected independent director. She currently serves as the Chief Financial Officer and Group Vice President of Toyota Motor North America, bringing substantial financial and executive leadership experience.
The Board's size was increased from nine to ten directors to accommodate the appointment of Ms. Doi, following a recommendation from the Board's Governance Committee.
Ms. Doi has been appointed to two key Board committees: the Audit and Finance Committee and the Cybersecurity Committee, reflecting her financial expertise and the company's focus areas.
Ms. Doi will receive compensation consistent with the company's standard practices for non-employee directors. This includes a one-time grant of restricted share units valued at $135,617 upon her appointment.